Freeline Therapeutics Holdings plc

CIK 1810031 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Freeline Therapeutics Holdings plc.

Recent SEC filings

FiledFormAccession number
Mar 1, 202415-12G0001193125-24-055923
Feb 23, 2024EFFECT9999999995-24-000522
Feb 22, 2024S-8 POS0001193125-24-042880
Feb 22, 2024S-8 POS0001193125-24-042891
Feb 22, 2024POS AM0001193125-24-042869
Feb 22, 2024SC 13D/A0001193125-24-042827
Feb 22, 2024S-8 POS0001193125-24-042885
Feb 22, 2024S-8 POS0001193125-24-042877
Feb 20, 20246-K0001193125-24-039335
Feb 20, 2024SC 13E3/A0001193125-24-039888
Feb 20, 202425-NSE0001354457-24-000099
Feb 14, 2024SC 13G/A0001580642-24-000984
Feb 12, 20246-K0001193125-24-032008
Feb 12, 2024SC 13G/A0001319244-24-000027
Jan 31, 2024SC 13G/A0000902664-24-000838
Jan 18, 20246-K0001193125-24-010208
Jan 17, 2024SC 13E3/A0001193125-24-009263
Dec 8, 2023SC 13E30001193125-23-291805
Dec 1, 20236-K0000950170-23-067157
Nov 24, 2023SC 13D/A0001193125-23-282577
Nov 22, 20236-K0001193125-23-281920
Oct 25, 20236-K0000950170-23-054983
Oct 18, 20236-K0000950170-23-053874
Oct 18, 2023SC 13D/A0001193125-23-258012
Oct 6, 20236-K0000950170-23-052427